MMMontserrat Alheli Melgarejo-Gutiérrez

Montserrat Alheli Melgarejo-Gutiérrez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Montserrat Alheli Melgarejo-Gutiérrez has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Physico-chemical properties analysis from the docking of some imidazole derivatives with the Ebola-viral matrix protein (VP40)

    by Magdalena Álvarez-Ramírez, Marcela Rosas-Nexticapa, Enrique Bonilla-Zavaleta, Montserrat Alheli Melgarejo-Gutiérrez, Martha Paola Rascón-Díaz, Abril Ramírez-Higuera

    Ebola is a serious and often fatal viral disease; it is important to mention that some compounds, such as azaguanine-8, favipiravir, and galidesivir, have been used to control this clinical pathology; however, the results are very poor due to their limited effectiveness. This study aimed to determine the docking of imidazole derivatives (1-43) with the VP40 protein involved in the structure of the Ebola virus, using the 5B0V protein as a theoretical tool in the DockingServer program. In addition, imidazole, azagaubine-8, estradiol benzoate, favipiravir, galidesivir, clotrimazole, and L-tetrahydropalmatine were used as controls. The results showed differences in the docking of imidazole derivatives with amino acid residues involved in the 5B0V protein surface compared with the controls. Besides, the Ki values for compounds 23, 24, and 39 were lower compared with the controls. Other data indicate that the Ki values for imidazole derivatives 19 and 42 were lower than those of estradiol benzoate, favipiravir, galidesivir, L-tetrahydropalmatine, and imidazole. Besides, the Ki values for the compounds 3, 17, 19, 21, 34, and 37 were lower in comparison with L-tetrahydropalmatine and imidazole. Finally, the compound's Ki value for 13 was lower compared with imidazole; all this data suggests that compounds 3, 13, 17, 19, 21, 23, 24, 34, 37, 39, and 42 may have a good affinity for the 5B0V protein and could act as VP40 protein inhibitors.

  • Open Access

    Coupling of Some Fluoride Derivatives to VEGFR-1 and EPHB4 Using a Theoretical Model

    by Enrique Bonilla-Zavaleta, Marcela Rosas Nexticapa, Magdalena Alvarez-Ramirez, Montserrat Alheli Melgarejo-Gutiérrez, Martha Paola Rascon-Diaz, Abril Ramírez-Higuera

    Several drugs such as sanguinarine, NVP-VHG712, QDAU5, and VDAU1-11 have been used to treat some cancer cells; however, their interaction with VEGFR-1 AND EPHB4 is not clear. For this reason, in this study, the coupling of some fluoride derivatives (1-36) with VEGFR-1 AND EPHB4 was determined using the 2VWX and 3HNG proteins as theoretical tools. In addition, sanguinarine, NVP-BHG712, QDAU5, and VDAU-11 were used as controls in the DockingServer program. The results showed differences in the number of amino acid residues involved in the coupling of fluoride analogs with the 2VWX and 3HNG proteins compared with the controls. Besides, the fluoride derivatives 6 and 10 have a higher affinity for the 2VWXprotein surface compared to the compounds 1, 3-5, 7-9, and 11-36. Other data indicate that fluorinated analogs 6, 12, 27, and 29 have a higher affinity for the 3HNG protein compared to the compounds 1-5, 7-11, 13-26, and 30-36. In conclusion, these data suggest that the fluorinated derivatives 6, 10, 12, 27, and 29 could act as inhibitors of EGFR-1 and EPHB4. Therefore, these compounds could be good candidates for evaluating their activity in some biological model.

  • Open Access

    Comprehensive bioinformatic analysis identifies some indole derivatives for treating cTnT-associated hypertrophic cardiomyopathy

    by Marcela Rosas-Nexticapa, Magdalena Álvarez-Ramírez, Enrique Bonilla-Zavaleta, Montserrat Alheli Melgarejo-Gutiérrez, Martha Paola Rascón-Díaz, Abril Ramírez-Higuera

    Alterations in cardiac troponin (cTnT) levels have been observed to be associated with the development of hypertrophic cardiomyopathy. It is worth noting that some drugs have been used to treat hypertrophic cardiomyopathy; however, these drugs act as myosin inhibitors. In the search for a therapeutic alternative for the treatment of this clinical pathology, this study aimed to determine the interaction of some indole derivatives (1-43) with cTnT using the 2n7l protein as a theoretical tool in the DockingServer program. Besides, the compounds indole, bepridil, levosimedam, and DPISTA were used as controls. The results showed differences in the number of amino acid residues involved in the docking of indole derivatives with the 2n7l protein surface compared to the controls. Other results indicate that the Ki values for indole derivatives 2, 4, 11, and 43 were lower compared with compounds 1, 3, 5-10, 12-42, beperidil, indole, and levosimedam. All these data suggest that compounds 2, 4, 11, and 43 may have good affinity for the 2n7l protein surface, which could lead to changes in the biological activity of cTnT. Therefore, these compounds could represent promising candidates for further experimental evaluation using a hypertrophic cardiomyopathy model.

  • Open Access

    Comprehensive bioinformatic analysis identifies some alkyne derivatives for treating MYH7-associated hypertrophic cardiomyopathy

    by Enrique Bonilla-Zavaleta, Marcela Rosas Nexticapa, Magdalena Alvarez-Ramirez, Montserrat Alheli Melgarejo-Gutiérrez, Martha Paola Rascon-Diaz, Abril Ramírez-Higuera

    Some studies indicate that mutations in the MYH7 gene are associated with hypertrophic cardiomyopathy. It is important to mention that several drugs have been used to treat hypertrophic cardiomyopathy, such as omecamtiv mecarbil, blebbistatin, mavacamten, and aficamten; however, it is necessary to develop a series of drugs that may interact with the MYH7 gene for therapeutic purposes in the treatment of this clinical pathology. For this reason, the aim of this study was to determine the coupling of some alkyne derivatives (1-35) with MYH7 using the 5cj1 protein as a theoretical tool. Besides, omecamtiv mecarbil, blebbistatin, and mavacamten and aficamten drugs were used as controls in the DockingServer program. The results showed differences in the number of aminoacid residues involved in the interaction of alkyne analogues (1-35) with the 5cj1 protein surface compared to the controls. Other data indicate that the inhibition constant (Ki) was higher for alkyne derivatives 7, 12, and 34 compared with the omecamtiv mecarbil, blebbistatin, and mavacamten drugs. However, the Ki for compounds 7, 12, and 34 was lower compared to the alkyne derivatives 1-6, 8-11, 13-33, and 35. These data suggest that compounds 7, 12, and 34 may have good affinity for the 5cj1 protein surface, which could lead to inhibition of the biological activity of MYH7. Therefore, these compounds could represent promising candidates for further experimental evaluation using a hypertrophic cardiomyopathy model.

  • Open Access

    Molecular-docking of some Amines and Furane Derivatives with IRAK-4 Using a Theoretical Model

    by Rosas-Nexticapa Marcela, Alvarez-Ramirez Maria Magdalena, Bonilla-Zavaleta Enrique, Melgarejo-Gutiérrez Montserrat Alheli, Ramírez-Higuera Abril

    For several years, some IRAK-4 inhibitors have been developed to treat chronic lymphocytic leukemia; however, their interaction with the IRAK-4 kinase is unclear. The aim of this study was to evaluate the interaction of some amine and furanone derivatives with IRAK-4 as a therapeutic alternative to treat chronic lymphocytic leukemia. The theoretical coupling of amine and furanone derivatives with the IRAK-4 was carried out using the 5uit protein as a theoretical model. Besides, 1-439 PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib drugs were used as controls in the DockingServer program. The results displayed different types of amino acid residues involved in the interaction of amine and furanone derivatives with the 5uit protein surface compared to the controls. Besides, the inhibition constant was lower for amino derivatives 3, 9, 25, 33, and 36 compared with the controls. Other data indicate that the inhibition constant was lower for furanone analogs 1, 3, 7, 13, 27, 32, and 34 compared with PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib. In conclusion, theoretical data indicate that amine (3, 9, 25, 33, and 36) and furanones (1, 3, 7, 13, 27, 32, and 34) derivatives might have a higher affinity for the 5uit protein surface compared with the controls. This data suggests that both amino and furanone derivatives can act as IRAK-4 inhibitors, which may serve to treat chronic lymphocytic leukemia.

  • Open Access

    Sleep Alterations in the Population of the Metropolitan Area of Mexico and Their Association with Lifestyle Changes During COVID-19 Confinement

    by María del Rosario Ayala-Moreno, Paola Andrea Martínez-Serrano, Montserrat Alheli Melgarejo-Gutiérrez, Alma Rosa Hernández-Mondragón, Azucena Martínez-Basila, Araceli Martínez-Coronado, María José Losana-Valencia, Esther Vargas-Medina, Eloisa Colín-Ramírez, Adriana Benítez-Rico

    Home confinement due to Coronavirus Disease 2019 (COVID-19) led to lifestyle changes that increased sleep disturbances, particularly in areas with higher infection and mortality rates. This study is a retrospective study based on data collected through an online survey conducted during the COVID-19 confinement. It aims to analyze changes in sleep quantity and quality and their association with lifestyle changes in the metropolitan area of Mexico City. A total of 899 adults from this area completed an online questionnaire between June 2020 and February 2021. This study assessed sleep quantity, sleep quality, insomnia symptoms, and lifestyle changes during the confinement period. Results showed that sleep quantity increased (7.10 ± 1.37 vs. 7.43 ± 1.42 h, p < 0.0001), with more participants, especially young adults and women, reporting later bed and wake-up times. The Pittsburgh Sleep Quality Index increased by 1.4 units, with poor sleep quality associated with lifestyle during confinement. Insomnia symptoms, sleep latency, and poor sleep quality also increased, particularly in women. Males and those without chronic comorbidities were less likely to experience poor sleep quality, while tobacco use and later bedtimes increased this risk. This study concludes that, while sleep quantity increased, sleep quality declined, particularly among young adults, women, and those with unhealthy lifestyles. These findings could guide sleep health initiatives tailored to specific lifestyle changes in different population groups.

  • Open Access

    Biochemical interaction of twenty steroid derivatives with ribosomal protein kinase 4 S6 (RSK-4) surface using a theoretical model

    by Lauro Figueroa-Valverde, Francisco Diaz-Cedillo, Marcela Rosas Nexticapa, Magdalena Alvarez-Ramirez, Maria López-Ramos, Montserrat Melgarejo-Guttierrez, Catalina Cervantes-Ortega, Maria Virginia Mateu-Armad, Juliette Mijangos-Sanchez

    Several genetic expressions have been involved in the development of cancer such as the expression of a ribosomal kinase S6 P90 (RSK-4). It is important to mention that some compounds such as LJH685, 2073047-06-8, and SL0101 can act as RSK-4 inhibitors; however, its interaction with the surface of RSK-4 is very confusing. The aim of this research was to evaluate the interaction of twenty-nine steroid derivatives (1 to 29) with of RSK-4 surface using 6rv2 protein, LJH685, 2073047-06-8 and SL0101 as theoretical tools in the Dockingserver program. The results showed differences in the aminoacid residues involved in the interaction of steroid derivatives with 6rv2 protein surface compared with LJH685, 2073047-06-8 and SL0101. Besides, the inhibition constant for steroid derivatives 1, 12, 14, 19 and 22 was lower compared to 2073047-06-8 drug. In conclusion, the steroid derivatives 1, 12, 14, 19 and 22 could be a good alternative as RSK-4 inhibitors to decrease cancer cells growth.